Spyre Therapeutics, Inc. · NASDAQ:SYRE

King-Jones Heidy sold 28,933 Spyre Therapeutics, Inc. shares (Form 4)

Traded Oct 1, 2026 · Filed Oct 2, 2026

On Oct 1, 2026, King-Jones Heidy (See Remarks) sold 28,933 Spyre Therapeutics, Inc. shares at an average US$91.03 for US$2.63M under a trading plan, leaving 2,845 shares. Filed Oct 2, 2026 (Form 4).

Sold
28,933 shares
Price
US$91.03 average (US$89.24 to US$93.46)
Value
US$2.63M
Holding after
2,845 shares
Trading plan
Yes (Made under a plan set in advance)
Role
See Remarks

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Oct 1, 2026Common StockOption exercise28,933US$14.5031,778Direct
Oct 1, 2026Common StockSale400US$89.2431,378Direct
Oct 1, 2026Common StockSale16,605US$90.3514,773Direct
Oct 1, 2026Common StockSale7,228US$91.357,545Direct
Oct 1, 2026Common StockSale2,100US$92.705,445Direct
Oct 1, 2026Common StockSale2,600US$93.462,845Direct

Source

View original at SEC

Related